Atrophy of the Corpus Callosum, Cortical Hypometabolism, and Cognitive Impairment in Corticobasal Degeneration
Open Access
- 1 May 1998
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 55 (5) , 609-614
- https://doi.org/10.1001/archneur.55.5.609
Abstract
CORTICOBASAL degeneration (CBD) is a neurodegenerative disorder with a distinctive asymmetrical akinetic-rigid syndrome in which cerebral cortical signs are the characteristic features.1,2 The clinical presentation of cortical dysfunction ranges from the localized cortical signs, including apraxia, cortical sensory loss, alien hand signs, and cortical reflex myoclonus, to generalized cognitive disturbance.3,4 Although these cortical signs may be the result of the involvement of specific regions that are important for higher cerebral functions, the mechanisms of cerebral cortical dysfunction in this disease are not completely clarified.Keywords
This publication has 11 references indexed in Scilit:
- III. Cortical-Basal Ganglionic DegenerationPublished by Georg Thieme Verlag KG ,2007
- Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsyAnnals of Neurology, 1997
- Corpus callosum atrophy in amyotrophic lateral sclerosisJournal of the Neurological Sciences, 1995
- Corticobasal degeneration: A clinical study of 36 casesBrain, 1994
- The nature of apraxia in corticobasal degeneration.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Large‐scale neurocognitive networks and distributed processing for attention, language, and memoryAnnals of Neurology, 1990
- General Organization of Callosal Connections in the Cerebral CortexPublished by Springer Nature ,1986
- Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of methodAnnals of Neurology, 1979
- Corticodentatonigral Degeneration With Neuronal AchromasiaArchives of Neurology, 1968